Skip to main content

Norgestrel and Ethinyl Estradiol Medicare Part D Coverage

Brand name: Cryselle
Dosage form
KIT
95%
of Medicare Part D plans
cover Norgestrel and Ethinyl Estradiol
5,255 of 5,530 plans
2.3
Avg. formulary tier
$15.00
Median 30-day copay
$0.00–$30.00
Copay range

Formulary Tier Distribution

How Medicare Part D plans classify Norgestrel and Ethinyl Estradiol. Lower tiers = lower copays.

Tier 1 - Preferred Generic 5%
266 plans • avg $0.00/mo
Tier 2 - Generic 64%
3,352 plans • avg $1.51/mo
Tier 3 - Preferred Brand 25%
1,305 plans • avg $1.55/mo
Tier 4 - Non-Preferred Drug 6%
332 plans • avg $1.33/mo

Find the cheapest plan for Norgestrel and Ethinyl Estradiol

Enter your ZIP code to compare every plan in your area side-by-side.

Compare Plans for Norgestrel and Ethinyl Estradiol →

Get Norgestrel and Ethinyl Estradiol Delivered to Your Door

Compare prices and get discounts from trusted online pharmacies

DrugCovered may earn commissions from pharmacy purchases. Prices and availability vary. Always consult your doctor before starting or changing medications.

Norgestrel and Ethinyl Estradiol Medicare Coverage by State

Coverage rates and average costs vary significantly by state. Click a state to see the specific plans available there.

Frequently Asked Questions about Norgestrel and Ethinyl Estradiol

95% of Medicare Part D plans cover Norgestrel and Ethinyl Estradiol. It is most commonly placed on Tier 2. Coverage varies by plan and geographic area.

The median 30-day copay for Norgestrel and Ethinyl Estradiol on Medicare Part D is $15.00 at a preferred pharmacy. Costs range from $0.00 to $30.00 depending on the plan.

Norgestrel and Ethinyl Estradiol is placed on Tier 2 by most Medicare Part D plans. Lower tier numbers generally mean lower copays.

0% of plans require prior authorization for Norgestrel and Ethinyl Estradiol. Prior authorization means your doctor must confirm the drug is medically necessary before the plan will cover it.

Coverage statistics based on CMS formulary data for plan year 2026. Data updated regularly. Methodology →